Boehringer Ingelheim Launches Free Comprehensive PRRS Handbook

PRRS Knowledge Manual

Duluth, Ga. (November 21, 2022) — Boehringer Ingelheim announced today the launch of the PRRS Knowledge Manual, a handbook chronicling 25+ years of porcine reproductive and respiratory syndrome virus (PRRSV) research and best practices for control.  

Compiling collaborative research and global perspectives from a variety of sources across academia and swine production, the PRRS Knowledge Manual offers one of the industry’s most comprehensive overviews of PRRSV history, immunology, as well as practical advice for prevention and control. Chapter topics include:  

  • Foundations of PRRS – Information related to PRRSV immunity and the economic impact of the virus.  

  • Principles of PRRS Control – Detailing the three core pillars of PRRS control: maximize immunity, minimize exposure/transmission, and measure and monitor with diagnostics.  

  • The Role of Vaccine-Derived Immunity – Outlining the direct and indirect benefits of vaccination. 

  • Implementation of PRRS Control Strategies – Best practices for control, including the 5-Step Process and Infection Chain® methodologies created by Boehringer Ingelheim.  

“We have made tremendous strides in PRRS management over the last 25 years, none of which would have been possible without the dedication of academic researchers, veterinarians and producers in the field,” said Reid Philips, DVM, Technical Manager for PRRS at Boehringer Ingelheim U.S. Swine Division. “We are proud to collaborate with these groups to bridge knowledge gaps and advance PRRS control strategies, in turn improving health and performance of pigs and the bottom line for producers.”  

As has been true for many years, PRRS is still the most economically significant disease affecting the U.S. swine industry1 with economic losses from PRRS estimated at $664 million annually, or $1.8 million per day.2 Continuous, collaborative research has proven critical to advancing the industry’s ability to manage this devastating virus.  
“As the company that brought the industry’s first modified-live PRRS vaccine to market, Boehringer Ingelheim is committed to continuing its legacy in PRRS protection,” said Lara Sheeley, Executive Director of Swine and Poultry Divisions at Boehringer Ingelheim. “The PRRS Knowledge Manual is a milestone in this legacy, documenting more than 25 years of progress in PRRS management, but also celebrating the community of industry professionals who made that progress possible.”  

To download a free copy of the PRRS Knowledge Manual visit



1Iowa State University College of Veterinary Medicine website. Porcine reproductive and respiratory syndrome (PRRS). Available at: Accessed July 7, 2019.  

2Holtkamp DJ, Kliebenstein JB, Neumann EJ, et al. Assessment of the economic impact of porcine reproductive and respiratory syndrome virus on U.S. pork producers. J Swine Health Prod 2013;21(2):72–84.


About Boehringer Ingelheim Animal Health USA 

Boehringer Ingelheim Animal Health is working on first-in-class innovation for the prediction, prevention, and treatment of diseases in animals. For veterinarians, pet owners, producers, and governments in more than 150 countries, we offer a large and innovative portfolio of products and services to improve the health and well-being of companion animals and livestock. 

As a global leader in the animal health industry and as part of the family-owned Boehringer Ingelheim, we take a long-term perspective. The lives of animals and humans are interconnected in deep and complex ways. We know that when animals are healthy, humans are healthier too. By using the synergies between our Animal Health and Human Pharma businesses and by delivering value through innovation, we enhance the health and well-being of both.  

Boehringer Ingelheim Animal Health has deep roots in the U.S. From a start in St. Joseph, Missouri, more than 100 years ago, it has grown to encompass seven sites. Boehringer Ingelheim Animal Health’s portfolio contains widely used and well-respected vaccines, parasite-control products and therapeutics for pets, horses and livestock. 

Learn more about Boehringer Ingelheim Animal Health USA at


Media Contacts

Lauren Curlett 
PR Supervisor 
(302) 632-3661 

Cortney Malter 
Corporate Communications 
Boehringer Ingelheim Animal Health USA Inc. 
(816) 922-9025  


INFECTION CHAIN® is a registered trademark of Boehringer Ingelheim Vetmedica GmbH, used under license.
©2023 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All Rights Reserved. US-POR-0382-2022